UK markets closed

AbbVie Inc. (0QCV.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
146.95-0.42 (-0.28%)
At close: 07:14PM BST
Full screen
Previous close147.37
Bid0.00 x N/A
Ask0.00 x N/A
Day's range146.93 - 147.40
52-week range146.93 - 147.40
Avg. volumeN/A
Market cap2.191B
Beta (5Y monthly)0.56
PE ratio (TTM)0.21
EPS (TTM)6.97
Earnings date26 Apr 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands

    Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is offering consumers an opportunity to be featured in upcoming campaigns for their biggest brands, including BOTOX® Cosmetic, the JUVÉDERM® Collection of Fillers, and Allē, the Allergan Aesthetics loyalty rewards program. Beginning today, consumers—including existing patients and those who are considering aesthetic treatment—can apply for a chance to be included in future brand campaigns. The first Allergan Aesthetics open casting call for BO


    3 top US dividend stocks for value investors to consider in 2024

    I’m searching far and wide to find the best dividend stocks that money can buy. Do the Americans have more to offer when it comes to value investing? The post 3 top US dividend stocks for value investors to consider in 2024 appeared first on The Motley Fool UK.

  • PR Newswire

    Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis

    AbbVie (NYSE: ABBV) today announced positive top-line results from SELECT-GCA, a Phase 3, multicenter, randomized, double-blind, placebo-controlled study, showing upadacitinib (RINVOQ®; 15 mg, once daily) in combination with a 26-week steroid taper regimen achieved its primary endpoint of sustained remissiona from week 12 through week 52 in adults with giant cell arteritis (GCA). In this study, 46 percent of patients receiving upadacitinib 15 mg in combination with a 26-week steroid taper regime